 Danielle Cooke
Concepts (465)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 26 | 2022 | 51 | 6.280 |
Why?
| | Embolization, Therapeutic | 28 | 2023 | 179 | 6.030 |
Why?
| | Intracranial Aneurysm | 20 | 2022 | 92 | 5.640 |
Why?
| | Endovascular Procedures | 22 | 2022 | 269 | 4.480 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 60 | 2.460 |
Why?
| | Endothelial Cells | 8 | 2022 | 696 | 2.450 |
Why?
| | Cerebral Angiography | 24 | 2024 | 111 | 2.400 |
Why?
| | Stents | 11 | 2022 | 477 | 2.240 |
Why?
| | Central Nervous System Vascular Malformations | 11 | 2022 | 23 | 2.210 |
Why?
| | Stroke | 19 | 2023 | 1017 | 2.180 |
Why?
| | Biopsy | 7 | 2022 | 1056 | 2.120 |
Why?
| | Angiography, Digital Subtraction | 16 | 2022 | 44 | 1.920 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 34 | 1.890 |
Why?
| | Tomography, X-Ray Computed | 18 | 2022 | 2393 | 1.590 |
Why?
| | Arteriovenous Fistula | 7 | 2021 | 29 | 1.590 |
Why?
| | Robotics | 3 | 2024 | 78 | 1.550 |
Why?
| | Brain Ischemia | 10 | 2022 | 298 | 1.250 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 76 | 1.240 |
Why?
| | Basilar Artery | 2 | 2018 | 6 | 1.220 |
Why?
| | Feasibility Studies | 6 | 2022 | 748 | 1.150 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 21 | 1.120 |
Why?
| | Retinoblastoma | 4 | 2018 | 26 | 1.120 |
Why?
| | Fluoroscopy | 8 | 2018 | 141 | 1.120 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 17 | 1.110 |
Why?
| | Neurosurgery | 2 | 2022 | 26 | 0.960 |
Why?
| | Humans | 133 | 2024 | 115741 | 0.940 |
Why?
| | Iliac Artery | 2 | 2014 | 44 | 0.930 |
Why?
| | Magnetic Resonance Imaging | 19 | 2021 | 3122 | 0.920 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 138 | 0.910 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 20 | 0.880 |
Why?
| | Software | 4 | 2020 | 541 | 0.880 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 847 | 0.870 |
Why?
| | Radiosurgery | 8 | 2022 | 298 | 0.860 |
Why?
| | Vascular Malformations | 5 | 2022 | 47 | 0.860 |
Why?
| | Thrombectomy | 8 | 2022 | 53 | 0.850 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 96 | 0.850 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 34 | 0.830 |
Why?
| | Aneurysm | 3 | 2021 | 29 | 0.830 |
Why?
| | Retrospective Studies | 53 | 2024 | 12633 | 0.830 |
Why?
| | Middle Aged | 55 | 2024 | 27069 | 0.800 |
Why?
| | Brain | 15 | 2022 | 2373 | 0.780 |
Why?
| | Carotid Stenosis | 1 | 2022 | 79 | 0.760 |
Why?
| | Male | 72 | 2024 | 56050 | 0.740 |
Why?
| | Cerebral Arteries | 4 | 2017 | 55 | 0.740 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 240 | 0.730 |
Why?
| | Balloon Occlusion | 1 | 2020 | 26 | 0.720 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 61 | 0.700 |
Why?
| | Vascular Access Devices | 3 | 2018 | 24 | 0.690 |
Why?
| | Veins | 3 | 2022 | 57 | 0.690 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 88 | 0.690 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 30 | 0.690 |
Why?
| | Radiography, Interventional | 4 | 2018 | 111 | 0.680 |
Why?
| | Treatment Outcome | 32 | 2023 | 9162 | 0.680 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.680 |
Why?
| | Melphalan | 3 | 2018 | 29 | 0.660 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 102 | 0.650 |
Why?
| | Needles | 2 | 2018 | 52 | 0.640 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 15 | 0.630 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 35 | 0.620 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 399 | 0.620 |
Why?
| | Wounds, Stab | 1 | 2018 | 11 | 0.620 |
Why?
| | Female | 70 | 2024 | 60018 | 0.610 |
Why?
| | Aged | 41 | 2024 | 19294 | 0.610 |
Why?
| | Jugular Veins | 1 | 2018 | 38 | 0.600 |
Why?
| | Neck Injuries | 1 | 2018 | 18 | 0.600 |
Why?
| | Nerve Net | 5 | 2020 | 228 | 0.590 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 262 | 0.570 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 18 | 0.560 |
Why?
| | Adult | 43 | 2024 | 30789 | 0.540 |
Why?
| | Angioplasty | 3 | 2022 | 40 | 0.520 |
Why?
| | Neuroimaging | 5 | 2020 | 248 | 0.510 |
Why?
| | Orbital Diseases | 2 | 2018 | 25 | 0.500 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 7 | 0.500 |
Why?
| | Disease Management | 3 | 2017 | 563 | 0.500 |
Why?
| | Renal Dialysis | 1 | 2018 | 369 | 0.490 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 69 | 0.480 |
Why?
| | Neural Pathways | 4 | 2020 | 260 | 0.470 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 71 | 0.460 |
Why?
| | Magnetic Fields | 2 | 2014 | 22 | 0.460 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 243 | 0.460 |
Why?
| | Cell Separation | 1 | 2013 | 293 | 0.420 |
Why?
| | Transcranial Magnetic Stimulation | 3 | 2020 | 43 | 0.420 |
Why?
| | Mammary Arteries | 1 | 2012 | 6 | 0.410 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 45 | 0.410 |
Why?
| | Spinal Cord | 3 | 2023 | 351 | 0.410 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 114 | 0.410 |
Why?
| | Clinical Protocols | 3 | 2018 | 233 | 0.410 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 18 | 0.410 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 38 | 0.410 |
Why?
| | Catheters | 4 | 2017 | 66 | 0.400 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 228 | 0.390 |
Why?
| | Sclerotherapy | 4 | 2022 | 19 | 0.390 |
Why?
| | Transcriptome | 3 | 2022 | 736 | 0.380 |
Why?
| | Atherosclerosis | 1 | 2015 | 342 | 0.380 |
Why?
| | Radial Artery | 2 | 2021 | 64 | 0.380 |
Why?
| | Temporal Arteries | 1 | 2011 | 47 | 0.370 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 34 | 0.370 |
Why?
| | Obsessive-Compulsive Disorder | 2 | 2022 | 32 | 0.360 |
Why?
| | Neuronavigation | 1 | 2010 | 7 | 0.360 |
Why?
| | Surgical Instruments | 1 | 2010 | 48 | 0.350 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 35 | 0.350 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 24 | 0.340 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 275 | 0.340 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 7 | 0.330 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 538 | 0.330 |
Why?
| | Connectome | 5 | 2020 | 63 | 0.320 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 203 | 0.320 |
Why?
| | Aged, 80 and over | 12 | 2022 | 6423 | 0.320 |
Why?
| | Magnetics | 4 | 2016 | 38 | 0.310 |
Why?
| | Vasodilator Agents | 1 | 2010 | 308 | 0.310 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 6 | 0.310 |
Why?
| | Foramen Magnum | 2 | 2021 | 9 | 0.310 |
Why?
| | Contrast Media | 4 | 2020 | 369 | 0.300 |
Why?
| | Brain Mapping | 5 | 2020 | 522 | 0.300 |
Why?
| | Brain Neoplasms | 1 | 2015 | 980 | 0.290 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 15 | 0.290 |
Why?
| | Cohort Studies | 11 | 2023 | 4949 | 0.270 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 68 | 0.260 |
Why?
| | Child | 24 | 2023 | 18503 | 0.260 |
Why?
| | Preoperative Care | 3 | 2021 | 319 | 0.260 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 9 | 0.260 |
Why?
| | Risk Factors | 8 | 2022 | 8702 | 0.260 |
Why?
| | Young Adult | 15 | 2022 | 10518 | 0.260 |
Why?
| | Embolectomy | 2 | 2017 | 10 | 0.250 |
Why?
| | Meningioma | 2 | 2016 | 78 | 0.250 |
Why?
| | Catheterization | 2 | 2017 | 159 | 0.250 |
Why?
| | Mutation | 5 | 2021 | 3364 | 0.250 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.240 |
Why?
| | Infant | 12 | 2022 | 7979 | 0.230 |
Why?
| | Mosaicism | 2 | 2021 | 60 | 0.230 |
Why?
| | Perfusion Imaging | 3 | 2022 | 55 | 0.230 |
Why?
| | Microsurgery | 2 | 2021 | 61 | 0.230 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 540 | 0.230 |
Why?
| | Adolescent | 21 | 2023 | 17922 | 0.220 |
Why?
| | Radiography | 4 | 2014 | 828 | 0.220 |
Why?
| | Child, Preschool | 15 | 2021 | 9138 | 0.220 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 102 | 0.220 |
Why?
| | Swine | 6 | 2018 | 706 | 0.220 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 157 | 0.210 |
Why?
| | Cerebral Cortex | 3 | 2022 | 386 | 0.210 |
Why?
| | Flow Cytometry | 2 | 2017 | 1083 | 0.210 |
Why?
| | Ventriculostomy | 2 | 2013 | 17 | 0.200 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 48 | 0.200 |
Why?
| | Methamphetamine | 1 | 2022 | 52 | 0.200 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 7 | 0.190 |
Why?
| | Actins | 2 | 2013 | 383 | 0.190 |
Why?
| | Hematoma | 1 | 2021 | 50 | 0.190 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1127 | 0.190 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 83 | 0.190 |
Why?
| | Materials Testing | 2 | 2020 | 356 | 0.190 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 90 | 0.190 |
Why?
| | Phenotype | 5 | 2021 | 2839 | 0.190 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 63 | 0.190 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 24 | 0.190 |
Why?
| | Iodine Compounds | 1 | 2020 | 2 | 0.190 |
Why?
| | Gene Expression | 2 | 2017 | 1436 | 0.190 |
Why?
| | Moyamoya Disease | 1 | 2020 | 15 | 0.190 |
Why?
| | Equipment Design | 5 | 2015 | 517 | 0.190 |
Why?
| | Brain Infarction | 1 | 2020 | 22 | 0.180 |
Why?
| | Recurrence | 3 | 2020 | 953 | 0.180 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 115 | 0.180 |
Why?
| | Orbit | 2 | 2011 | 59 | 0.180 |
Why?
| | Growth Disorders | 1 | 2021 | 78 | 0.180 |
Why?
| | Nervous System Diseases | 2 | 2021 | 253 | 0.180 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 39 | 0.180 |
Why?
| | Blood Vessels | 1 | 2022 | 181 | 0.180 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 10 | 0.180 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 63 | 0.180 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 100 | 0.180 |
Why?
| | Models, Anatomic | 1 | 2020 | 92 | 0.180 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 7 | 0.180 |
Why?
| | Unconsciousness | 1 | 2020 | 18 | 0.180 |
Why?
| | Pyrimidinones | 1 | 2020 | 88 | 0.170 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 724 | 0.170 |
Why?
| | Observer Variation | 1 | 2020 | 301 | 0.170 |
Why?
| | Follow-Up Studies | 8 | 2021 | 4442 | 0.170 |
Why?
| | Multivariate Analysis | 2 | 2020 | 1441 | 0.170 |
Why?
| | Pyridones | 1 | 2020 | 125 | 0.170 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.170 |
Why?
| | Aspirin | 1 | 2022 | 326 | 0.170 |
Why?
| | Amnesia | 1 | 2019 | 42 | 0.170 |
Why?
| | Models, Neurological | 1 | 2021 | 213 | 0.170 |
Why?
| | Polyvinyls | 2 | 2016 | 17 | 0.170 |
Why?
| | Cerebral Infarction | 2 | 2022 | 39 | 0.160 |
Why?
| | Brain Stem | 1 | 2020 | 102 | 0.160 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 40 | 0.160 |
Why?
| | Pitch Perception | 1 | 2019 | 9 | 0.160 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 43 | 0.160 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 78 | 0.160 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 382 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2020 | 83 | 0.160 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 106 | 0.160 |
Why?
| | Rabbits | 2 | 2022 | 752 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2824 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 503 | 0.150 |
Why?
| | Vascular Patency | 1 | 2018 | 97 | 0.150 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 44 | 0.150 |
Why?
| | Family Health | 1 | 2019 | 195 | 0.150 |
Why?
| | Cell Count | 1 | 2019 | 305 | 0.150 |
Why?
| | Motivation | 1 | 2022 | 498 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1357 | 0.150 |
Why?
| | Retinal Vein | 1 | 2018 | 13 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 230 | 0.150 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.150 |
Why?
| | Depression | 3 | 2022 | 1147 | 0.150 |
Why?
| | Endoglin | 1 | 2017 | 20 | 0.150 |
Why?
| | Memory | 1 | 2019 | 212 | 0.150 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 69 | 0.150 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.150 |
Why?
| | von Willebrand Factor | 1 | 2017 | 56 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 415 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2018 | 151 | 0.150 |
Why?
| | Phlebography | 1 | 2017 | 40 | 0.140 |
Why?
| | Cochlear Implantation | 1 | 2019 | 80 | 0.140 |
Why?
| | Cochlear Implants | 1 | 2019 | 93 | 0.140 |
Why?
| | Retinal Diseases | 1 | 2018 | 77 | 0.140 |
Why?
| | Conscious Sedation | 1 | 2017 | 79 | 0.140 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 58 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2017 | 85 | 0.140 |
Why?
| | Microvessels | 1 | 2017 | 68 | 0.140 |
Why?
| | Mental Health | 1 | 2022 | 571 | 0.140 |
Why?
| | Thalamus | 1 | 2017 | 78 | 0.140 |
Why?
| | Workflow | 1 | 2017 | 136 | 0.140 |
Why?
| | Prospective Studies | 7 | 2021 | 6276 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2017 | 147 | 0.140 |
Why?
| | Depressive Disorder | 1 | 2019 | 336 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 384 | 0.130 |
Why?
| | Carotid Arteries | 1 | 2017 | 183 | 0.130 |
Why?
| | Meningeal Arteries | 1 | 2015 | 1 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 1893 | 0.130 |
Why?
| | Renal Artery | 1 | 2016 | 26 | 0.130 |
Why?
| | Tantalum | 1 | 2015 | 4 | 0.130 |
Why?
| | Ferrous Compounds | 1 | 2015 | 22 | 0.130 |
Why?
| | Magnets | 1 | 2015 | 15 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1537 | 0.130 |
Why?
| | Time Factors | 3 | 2022 | 6171 | 0.130 |
Why?
| | American Heart Association | 1 | 2017 | 266 | 0.130 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.130 |
Why?
| | Ferric Compounds | 1 | 2015 | 40 | 0.130 |
Why?
| | Hearing Loss | 1 | 2019 | 183 | 0.130 |
Why?
| | Hemodynamics | 2 | 2017 | 1024 | 0.130 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 88 | 0.130 |
Why?
| | Filtration | 1 | 2015 | 62 | 0.130 |
Why?
| | Genotype | 1 | 2020 | 1787 | 0.130 |
Why?
| | Aneurysm, False | 1 | 2015 | 46 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2022 | 5061 | 0.120 |
Why?
| | Collateral Circulation | 1 | 2015 | 19 | 0.120 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 23 | 0.120 |
Why?
| | Biopsy, Needle | 1 | 2015 | 183 | 0.120 |
Why?
| | Drug Carriers | 1 | 2015 | 113 | 0.120 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 38 | 0.120 |
Why?
| | Lasers | 1 | 2015 | 121 | 0.120 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 118 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 790 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 267 | 0.120 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2014 | 258 | 0.120 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 304 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2586 | 0.120 |
Why?
| | Decision Making | 1 | 2021 | 791 | 0.120 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 9 | 0.120 |
Why?
| | Recovery of Function | 1 | 2018 | 577 | 0.110 |
Why?
| | Reference Values | 1 | 2015 | 750 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 317 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 42 | 0.110 |
Why?
| | Skin | 2 | 2017 | 662 | 0.110 |
Why?
| | Optical Imaging | 1 | 2014 | 55 | 0.110 |
Why?
| | Prognosis | 6 | 2017 | 3343 | 0.110 |
Why?
| | Tungsten | 1 | 2013 | 26 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2013 | 135 | 0.110 |
Why?
| | Artifacts | 1 | 2014 | 123 | 0.110 |
Why?
| | Animals | 9 | 2022 | 32104 | 0.110 |
Why?
| | Alloys | 1 | 2013 | 31 | 0.110 |
Why?
| | Ketones | 1 | 2013 | 44 | 0.110 |
Why?
| | Electrocardiography | 1 | 1996 | 564 | 0.110 |
Why?
| | Neck | 2 | 2023 | 84 | 0.110 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 17 | 0.110 |
Why?
| | Radiation Dosage | 1 | 2014 | 139 | 0.110 |
Why?
| | Comorbidity | 2 | 2014 | 1473 | 0.100 |
Why?
| | Carboxypeptidases | 1 | 1992 | 14 | 0.100 |
Why?
| | Paresis | 1 | 2012 | 28 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 40 | 0.100 |
Why?
| | Zygoma | 1 | 2011 | 11 | 0.100 |
Why?
| | Health Personnel | 1 | 2017 | 582 | 0.100 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 102 | 0.100 |
Why?
| | Proteoglycans | 1 | 1992 | 107 | 0.100 |
Why?
| | Cranial Sinuses | 2 | 2021 | 12 | 0.100 |
Why?
| | Hot Temperature | 1 | 2013 | 303 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2022 | 3914 | 0.100 |
Why?
| | Ethanol | 1 | 2015 | 549 | 0.100 |
Why?
| | Parents | 1 | 2019 | 1207 | 0.100 |
Why?
| | Mast Cells | 1 | 1992 | 117 | 0.100 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 109 | 0.100 |
Why?
| | Predictive Value of Tests | 4 | 2020 | 1825 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 175 | 0.090 |
Why?
| | Quality of Life | 1 | 2022 | 2388 | 0.090 |
Why?
| | Cell Survival | 1 | 2013 | 1024 | 0.090 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 3 | 0.090 |
Why?
| | Angiography | 3 | 2018 | 178 | 0.090 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.090 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 47 | 0.090 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 16 | 0.090 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 29 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2020 | 99 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 420 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2353 | 0.080 |
Why?
| | Hydrocephalus | 1 | 2010 | 81 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 1996 | 931 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 1996 | 590 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 173 | 0.080 |
Why?
| | RNA | 1 | 2014 | 820 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 699 | 0.080 |
Why?
| | ROC Curve | 2 | 2022 | 451 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 576 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 210 | 0.080 |
Why?
| | Rupture | 2 | 2020 | 95 | 0.080 |
Why?
| | Arteries | 2 | 2022 | 250 | 0.080 |
Why?
| | Brain Injuries | 1 | 2013 | 451 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2020 | 1730 | 0.080 |
Why?
| | Registries | 1 | 2015 | 1770 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2019 | 3037 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2015 | 3580 | 0.070 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 25 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4669 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2018 | 428 | 0.060 |
Why?
| | Age Distribution | 2 | 2014 | 341 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1064 | 0.060 |
Why?
| | Models, Animal | 2 | 2016 | 350 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 56 | 0.050 |
Why?
| | Head | 1 | 2022 | 86 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 24 | 0.050 |
Why?
| | Age Factors | 2 | 2021 | 2911 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4448 | 0.050 |
Why?
| | Technology | 1 | 2022 | 80 | 0.050 |
Why?
| | Sodium | 1 | 2022 | 183 | 0.050 |
Why?
| | Mood Disorders | 1 | 2022 | 117 | 0.050 |
Why?
| | Aging, Premature | 1 | 2021 | 11 | 0.050 |
Why?
| | Skin Abnormalities | 1 | 2021 | 10 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 50 | 0.050 |
Why?
| | Intention | 1 | 2022 | 143 | 0.050 |
Why?
| | Survival Rate | 2 | 2014 | 1651 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 71 | 0.050 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 154 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 188 | 0.040 |
Why?
| | Canada | 1 | 2021 | 335 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 131 | 0.040 |
Why?
| | Headache | 1 | 2021 | 131 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 3 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 520 | 0.040 |
Why?
| | Coma | 1 | 2020 | 30 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 225 | 0.040 |
Why?
| | Fibroblasts | 2 | 2022 | 839 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 41 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 450 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 339 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 24 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 65 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2022 | 310 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 16 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 13 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 15 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 16 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 42 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 507 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2019 | 200 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2021 | 2164 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 42 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 321 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 58 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 465 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1001 | 0.040 |
Why?
| | Thiophenes | 1 | 1999 | 108 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2019 | 121 | 0.040 |
Why?
| | Problem Behavior | 1 | 2019 | 86 | 0.040 |
Why?
| | Paracentesis | 1 | 2018 | 7 | 0.040 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 25 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 19 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 618 | 0.040 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.040 |
Why?
| | Groin | 1 | 2017 | 13 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 443 | 0.040 |
Why?
| | Punctures | 1 | 2017 | 37 | 0.040 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 30 | 0.040 |
Why?
| | Speech Perception | 1 | 2019 | 80 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 301 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 204 | 0.040 |
Why?
| | United States | 3 | 2021 | 12304 | 0.040 |
Why?
| | Cerebellum | 1 | 2019 | 200 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 337 | 0.040 |
Why?
| | Parent-Child Relations | 1 | 2019 | 234 | 0.040 |
Why?
| | Carotid Artery, External | 1 | 2016 | 2 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 666 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 1998 | 140 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 58 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2000 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 880 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 3 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2420 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 7 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 316 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 8 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 447 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2017 | 485 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 334 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 89 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 854 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 180 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 309 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 337 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2269 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 120 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 151 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 319 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 177 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1356 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 299 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2019 | 438 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 99 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 941 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 378 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1335 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 9 | 0.030 |
Why?
| | Causality | 1 | 2014 | 106 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 2 | 0.030 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2018 | 552 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 324 | 0.030 |
Why?
| | Oxygen | 1 | 2017 | 837 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1996 | 1230 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 267 | 0.030 |
Why?
| | California | 1 | 2014 | 367 | 0.030 |
Why?
| | Cervical Vertebrae | 1 | 2013 | 106 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2129 | 0.030 |
Why?
| | Chymases | 1 | 1992 | 3 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 83 | 0.030 |
Why?
| | Chromatography, Gel | 1 | 1992 | 128 | 0.030 |
Why?
| | Molecular Weight | 1 | 1992 | 329 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 89 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2500 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1384 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5553 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 86 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 463 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1234 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4541 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2423 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2335 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 168 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1139 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 326 | 0.020 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 4 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 137 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 66 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 71 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 169 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 109 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 273 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 277 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 397 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 344 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 204 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 250 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1172 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|